Abstract
Although betulinic acid (BA) is known to induce apoptosis and antiangiogenic response in tumor cells, the underlying mechanism of its action is unknown. Deregulation of tissue collagen metabolism is one of the consequences of neoplastic transformation. The final step of collagen degradation is mediated by prolidase [E.C.3.4.13.9] which may play a role in angiogenesis. The formation of new blood vessels is regulated by the hypoxia-inducible factor 1 (HIF-1). The expression of HIF-1 correlates with hypoxia-induced angiogenesis as a result of the induction of vascular endothelial cell growth factor (VEGF). Since BA evokes anticancer activity, its effect on collagen biosynthesis, HIF-1α and VEGF expressions, as well as prolidase activity and expression was studied in cultured endometrial adenocarcinoma (EA) cells. It was found that BA inhibits collagen biosynthesis in EA cells (5[3H] proline incorporation assay). It was accompanied by a parallel decrease in prolidase activity and expression and decrease in expressions of α1 and α2 integrins, HIF-1α, and VEGF (western immunoblot analysis) in cultured human EA cells. The data suggest that BA may have anti-angiogenic potential by inhibition of prolidase, HIF-1α and VEGF expressions, and inhibition of collagen biosynthesis.
Similar content being viewed by others
References
Mukherjee PK, Saha K, Das J, Pal M, Saha BP (1997) Studies on the anti-inflammatory activity of rhizomes of Nelumbo nucifera. Planta Med 63:367–369
Yun Y, Han S, Park E et al (2003) Immunomodulatory activity of betulinic acid by producing proinflammatory cytokines and activation of macrophages. Arch Pharm Res 26:1087–1095
Wen CC, Kuo YH, Jan JT et al (2007) Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus. J Med Chem 50:4087–4095
Fulda S, Jeremias I, Steiner HH, Pietsch T, Debatin KM (1999) Betulinic acid: a new cytotoxic agent against malignant brain–tumor cells. Int J Cancer 82:435–441
Cichewicz RH, Kouzi SA (2004) Chemistry, biological activity, and chemotherapeutic potential of betulinic acid for the prevention and treatment of cancer and HIV infection. Med Res Rev 24:90–114
Eiznhamer DA, Xu ZQ (2004) Betulinic acid: a promising anticancer candidate. IDrugs 7:359–373
Chintharlapalli S, Papineni S, Ramaiah SK, Safe S (2007) Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res 67:2816–2823
Bissel M (1981) How does extracellular matrix direct gene expression? J Theor Biol 99:31–68
Carey DJ (1991) Control of growth and differentiation of vascular cells by extracellular matrix. Ann Rev Physiol 53:161–177
Ruoslahti E (1992) Control of cell motility and tumor invasion by extracellular matrix interaction. Br J Cancer 66:239–242
Arata J, Tada J, Yamada T, Oono T, Yasutomi H, Oka E (1991) Angiopathic pathogenesis of clinical manifestations in prolidase deficiency. Arch Dermatol 127:124–125
Choi KS, Bae MK, Jeong JW, Moon HE, Kim KW (2003) Hypoxia-induced angiogenesis during carcinogenesis. J Biochem Mol Biol 36:120–127
Kolev Y, Uetake H, Iida S, Ishikawa T, Kawano T, Sugihara K (2007) Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma. Ann Surg Oncol 14:2738–2747
Myara I, Charpentier C, Lemonnier A (1982) Optimal conditions for prolidase assay by proline colorimetric determination: application to imidopeptiduria. Clin Chim Acta 125:193–205
Lowry OH, Rosebrough NI, Farr AL, Randall RJ (1951) Protein measurement with the Folin reagent. J Biol Chem 193:265–275
Oyamada I, Pałka J, Schalk EM, Takeda K, Peterkofsky B (1990) Scorbutic and fasted guinea pig sera contain an insulin-like growth factor I reversible inhibitor of proteoglycan and collagen synthesis in chick embryo chondrocytes and adult human skin fibroblasts. Arch Biochem Biophys 276:85–93
Peterkofsky B, Chojkier M, Bateman J (1982) Determination of collagen synthesis in tissue and cell culture system. In: Furthmay H (ed) Immunochemistry of the extracellular matrix. CRC Press, Boca Raton, FL, pp 19–47
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680–685
Pałka JA, Phang JM (1997) Prolidase activity in fibroblasts is regulated by interaction of extracellular matrix with cell surface integrin receptors. J Cell Biochem 67:166–175
Zuco V, Supino R, Righetti SC et al (2002) Selective cytotoxicity of betulinic acid on tumor cell lines, but not on normal cells. Cancer Lett 175:17–25
Mock WL, Green PC, Boyer KD (1990) Specificity and pH dependence for acylproline cleavage by prolidase. J Biol Chem 265:19600
Surażyński A, Palka J, Wolczynski S (2001) Phosphorylation of prolidase increases the enzyme activity. Mol Cell Biochem 220:95–101
Surażyński A, Miltyk W, Pałka J, Phang JM (2008) Prolidase-dependent regulation of collagen biosynthesis. Amino Acids 35:731–738
Surazynski A, Donald SP, Cooper SK et al (2008) Extracellular matrix and HIF-1 signaling: the role of prolidase. Int J Cancer 122:1435–1440
Jaakkola P, Mole DR, Tian YM et al (2001) Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 292:468–472
Jacob SW, Herschler R (1986) Pharmacology of DMSO. Cryobiology 1:14–27
Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510–5514
Morley P, Whitfield JF (1993) The differentiation inducer, dimethyl sulfoxide, transiently increases the intracellular calcium ion concentration in various cell types. J Cell Physiol 156:219–225
Mottet D, Michel G, Renard P, Ninane N, Raes M, Michiels C (2003) Role of ERK and calcium in the hypoxia-induced activation of HIF-1. J Cell Physiol 194:30–44
Senger DR, Claffey KP, Benes JE, Perruzzi CA, Sergiou AP, Detmar M (1997) Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc Natl Acad Sci USA 94:13612–13617
Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604–4613
Jiang BH, Rue E, Wang GL, Roe R, Semenza GL (1996) Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J Biol Chem 271:17771–17778
Gleadle JM, Ratcliffe PJ (1997) Induction of hypoxia-inducible factor-1, erythropoietin, vascular endothelial growth factor, and glucose transporter-1 by hypoxia: evidence against a regulatory role for Src kinase. Blood 89:503–509
Iyer NV, Kotch LE, Agani F, Leung SW, Laughner E, Wenger RH, Gassmann M, Gearhart JD, Lawker AM, Yu AY, Semenza GL (1998) Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12:149–162
Sulkowska M, Wincewicz A, Sulkowski S, Koda M, Kanczuga-Koda L (2009) Relations of TGF-beta1 with HIF-1 alpha, GLUT-1 and longer survival of colorectal cancer patients. Pathology 41:254–260
Potter C, Harris AL (2004) Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 3:164–167
Robertson N, Potter C, Harris AL (2004) Role of carbonic anhydrase IX in human tumor cell growth, survival, and invasion. Cancer Res 64:6160–6165
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karna, E., Szoka, L. & Palka, J.A. Betulinic acid inhibits the expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in human endometrial adenocarcinoma cells. Mol Cell Biochem 340, 15–20 (2010). https://doi.org/10.1007/s11010-010-0395-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-010-0395-8